| 179.98 -0.41 (-0.23%) | 08-29 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 219.35 | 1-year : | 256.2 |
| Resists | First : | 187.8 | Second : | 219.35 |
| Pivot price | 182.95 |
|||
| Supports | First : | 177.81 | Second : | 171.64 |
| MAs | MA(5) : | 182.18 |
MA(20) : | 181.62 |
| MA(100) : | 182.55 |
MA(250) : | 169.44 |
|
| MACD | MACD : | 0.6 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 66.3 |
D(3) : | 57 |
| RSI | RSI(14): 54.9  |
|||
| 52-week | High : | 194.78 | Low : | 136.07 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ ABC ] has closed below upper band by 41.6%. Bollinger Bands are 7.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 185.16 - 186.1 | 186.1 - 186.83 |
| Low: | 180.62 - 181.63 | 181.63 - 182.4 |
| Close: | 182.27 - 183.94 | 183.94 - 185.23 |
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Thu, 25 Apr 2024
Read This Before You Buy AmerisourceBergen Corporation (NYSE:ABC) Because Of Its P/E Ratio - Yahoo Movies UK
Sun, 21 Apr 2024
Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio - Yahoo Singapore News
Fri, 05 Apr 2024
AmerisourceBergen Corporation (ABC) Soars to 52-Week High, Time to Cash Out? - Yahoo Movies Canada
Thu, 31 Aug 2023
AmerisourceBergen Rebrands as Cencora - HIT Consultant
Wed, 30 Aug 2023
AmerisourceBergen changes name to Cencora, ticker to COR (NYSE:COR) - Seeking Alpha
Wed, 30 Aug 2023
AmerisourceBergen becomes Cencora, in alignment with the company's growing global footprint and central role in ... - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 201 (M) |
| Shares Float | 169 (M) |
| Held by Insiders | 16.6 (%) |
| Held by Institutions | 78.9 (%) |
| Shares Short | 7,020 (K) |
| Shares Short P.Month | 3,810 (K) |
| EPS | 8.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.39 |
| Profit Margin | 0.6 % |
| Operating Margin | 1 % |
| Return on Assets (ttm) | 2.7 % |
| Return on Equity (ttm) | 233.6 % |
| Qtrly Rev. Growth | 11.5 % |
| Gross Profit (p.s.) | 41.47 |
| Sales Per Share | 1266.76 |
| EBITDA (p.s.) | 17.02 |
| Qtrly Earnings Growth | 22.3 % |
| Operating Cash Flow | 3,250 (M) |
| Levered Free Cash Flow | 3,310 (M) |
| PE Ratio | 22.39 |
| PEG Ratio | 1.7 |
| Price to Book value | 54.23 |
| Price to Sales | 0.14 |
| Price to Cash Flow | 11.36 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|